150 related articles for article (PubMed ID: 7197651)
1. Cipropride in preventing nausea and vomiting induced by severely emetic cytostatic agents.
Serrou B; Cupissol D; Rosenfeld C; Metz R; Coquelin JP; Sauvanet JP
J Int Med Res; 1981; 9(5):390-1. PubMed ID: 7197651
[No Abstract] [Full Text] [Related]
2. [A double-blind study of alizapride in nausea and emesis induced by cancer chemotherapeutic agents (author's transl)].
Viala JJ; Girard D; Cordier JF
Sem Hop; 1982 Feb; 58(6):371-4. PubMed ID: 6280306
[No Abstract] [Full Text] [Related]
3. Ondansetron for the control of dacarbazine-induced emesis.
Campora E; Chiara S; Aschele C
Eur J Cancer; 1995 Sep; 31A(10):1720-1. PubMed ID: 7488437
[No Abstract] [Full Text] [Related]
4. Domperidone (R 33812) in the prophylactic treatment of chemotherapy-induced emesis. A multicentre evaluation.
Nogarède J; Closon MT; Clarysse A; Longueville J; Derouaux M; Ferrant A; Drochmans A
Arzneimittelforschung; 1978; 28(4):686-8. PubMed ID: 581949
[TBL] [Abstract][Full Text] [Related]
5. [Chemotherapy of malignant tumors, vomiting and nausea--what to do?].
Ell C; König HJ
Fortschr Med; 1984 Oct; 102(37):913-5. PubMed ID: 6500448
[TBL] [Abstract][Full Text] [Related]
6. [Prevention of nausea and emesis during cytostatic therapy. Antiemetic efficacy of high-dosage oral metoclopramide without and with prednisone].
Senn HJ; Köhler M; Glaus A; Bachmann-Mettler I; Weigand W
Dtsch Med Wochenschr; 1986 Jan; 111(4):129-35. PubMed ID: 3510848
[TBL] [Abstract][Full Text] [Related]
7. [1 year's use of alizapride for the prevention and treatment of nausea and vomiting secondary to anticancer agents].
Olivier JP
Ann Gastroenterol Hepatol (Paris); 1985 Jan; 21(1):53-5. PubMed ID: 3977279
[No Abstract] [Full Text] [Related]
8. The efficacy of granisetron for cancer patients undergoing platinum-based chemotherapy: comparison of 1 miligram versus 3 miligram doses in preventing nausea and vomiting.
Kurnianda J; Hisyam B; Wahyuningsih E; Hutajulu SH
Acta Med Indones; 2005; 37(4):210-3. PubMed ID: 16317218
[TBL] [Abstract][Full Text] [Related]
9. Preventing chemotherapy-induced nausea and vomiting: an update and a review of emesis.
Ettinger DS
Semin Oncol; 1995 Aug; 22(4 Suppl 10):6-18. PubMed ID: 7570053
[No Abstract] [Full Text] [Related]
10. [Anti-emetic effect of ondansetron in cisplatin induced nausea and vomiting--a randomized clinical trial].
Zeng WY
Zhonghua Zhong Liu Za Zhi; 1992 Jul; 14(4):273-5. PubMed ID: 1396075
[TBL] [Abstract][Full Text] [Related]
11. [Prevention and therapy of cytostatic-induced vomiting].
Riess H; Ludat K
Dtsch Med Wochenschr; 1991 May; 116(18):705-12. PubMed ID: 2026101
[No Abstract] [Full Text] [Related]
12. Comparison of granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a randomized controlled trial.
Mantovani G; Macciò A; Bianchi A; Curreli L; Ghiani M; Proto E; Santona MC
Cancer; 1996 Mar; 77(5):941-8. PubMed ID: 8608488
[TBL] [Abstract][Full Text] [Related]
13. Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with cisplatin therapy: randomized, double-blind study protocol--EASE.
Grunberg S; Chua D; Maru A; Dinis J; DeVandry S; Boice JA; Hardwick JS; Beckford E; Taylor A; Carides A; Roila F; Herrstedt J
J Clin Oncol; 2011 Apr; 29(11):1495-501. PubMed ID: 21383291
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy-induced nausea and vomiting with special emphasis on metopimazine.
Herrstedt J
Dan Med Bull; 1998 Sep; 45(4):412-22. PubMed ID: 9777292
[No Abstract] [Full Text] [Related]
15. [An assessment tool for chemotherapy-induced nausea and vomiting and intervention outcomes].
Aimono Y; Suzuki S; Nemoto M; Saito Y; Aoyama Y; Joko F; Maruyama T; Kamoshida T
Gan To Kagaku Ryoho; 2013 Dec; 40(13):2551-4. PubMed ID: 24335368
[TBL] [Abstract][Full Text] [Related]
16. Management of chemotherapy-induced nausea and vomiting.
Zubairi IH
Br J Hosp Med (Lond); 2006 Aug; 67(8):410-3. PubMed ID: 16918094
[TBL] [Abstract][Full Text] [Related]
17. CLINICAL DECISIONS. Chemotherapy-Induced Nausea and Vomiting.
Wilbur MB; Birrer MJ; Spriggs DR
N Engl J Med; 2016 Jul; 375(2):177-9. PubMed ID: 27410928
[No Abstract] [Full Text] [Related]
18. Improved control of high-dose-cisplatin-induced acute emesis with the addition of prochlorperazine to granisetron/dexamethasone.
Hesketh PJ; Gandara DR; Hesketh AM; Edelman M; Webber LM; McManus M; Hainsworth JD
Cancer J Sci Am; 1997; 3(3):180-3. PubMed ID: 9161784
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic potential of Granisetron (Kitryl) for the prevention of nausea and vomiting induced by cytostatic drugs].
Gershanovich ML; Beresneva IA
Vopr Onkol; 1998; 44(2):225-8. PubMed ID: 9615833
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of SN-307 (ondansetron), given intravenously for the treatment of nausea and vomiting caused by anticancer drugs including cisplatin-open study].
Ikeda M; Taguchi T; Ota K; Furue H; Niitani H; Tsukagoshi S; Ariyoshi Y; Akasaka Y; Ohta J; Suminaga M
Gan To Kagaku Ryoho; 1992 Sep; 19(11):1905-14. PubMed ID: 1387776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
